TAMPA, Fla.--(BUSINESS WIRE)--Emerging nutraceuticals company Neutra Corp. (OTCBB:NTRR) announced today that it is investigating a cocktail of natural ingredients that could prevent acidosis, a painful medical condition that destroys the body from the inside out.
Two ingredients, Cesium chloride and rubidium chloride, are alkalizing minerals that-- when combined with potassium-- raises cells’ pH and oxygen content to a more alkaline, disease-resistant state. Since the onset of acidosis is directly related to pH levels within the body, individuals prone to higher pH levels may soon be able to ward off many chronic illnesses.
Acidosis begins when the body attempts to restore pH balance due to excess waste. In an effort to protect vital organs, harmful acids are diverted into tissues, joints and bones where it can be stored. Temporarily, the organs are safe, but the diversion can cause joint and skeletal problems such as Osteo and Rheumatoid arthritis, skin conditions such as dermatitis and eczema, tissue-related medical issues such as chronic fatigue and fibromyalgia as well as life-threatening conditions like cancer.
Maintaining a slightly alkaline pH level of 7.43 allows the body’s cells to communicate effectively, a process that is necessary to ensure a healthy immune system. Most people in the U.S. suffer from some form of acidosis, typically brought on by stress and unhealthy eating habits. That means there is a huge market developing for acidosis supplements. Neutra Corp.’s exploration into a possible alkalizer treatment option could be a major step in preventing acidosis as well as other diseases that thrive in a more acidic environment.
“Everyone knows or has someone in their family suffering from a condition or disease that could have been helped or prevented by simply strengthening the immune system,” said NTRR CEO Cindy Morrissey. “We feel development of a supplement that helps the body maintain a normal pH balance will in turn assist in maintaining a strong immune system and that is worth pursuing.”
Neutra Corp. is developing new products to compete in the rising nutraceuticals industry alongside Herbalife Ltd. (NYSE: HLF), Watson Pharmaceuticals, Inc. (NYSE:WPI), Plandai Biotechnology, Inc. (OTCOB: PLPL), LTS Nutraceuticals, Inc. (LTSN.PK), and Vitamin Shoppe, Inc. (NYSE: VSI).
For more information on NTRR’s nutraceuticals initiative, please visit www.neutracorp.com/investors.html.
Follow NTRR on Twitter at www.twitter.com/neutracorp.
About Neutra Corp.
Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit www.neutracorp.com/investors.html.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.